Novartis Introduces Pluvicto, India's First Approved Radioligand Therapy

SentiSense · Published Jun 15, 2026, 5:34 AM ET · Updated Jun 17, 2026, 10:44 AM ET

Novartis has launched Pluvicto, the first approved radioligand therapy for advanced prostate cancer in India. The treatment is for patients with prost...